HomeCME Courses AvailableAbout UsContact UsPrint

:: COPD Home

:: Faculty Disclosure    Information

:: Accreditation Information

:: Goals & Objectives

:: References & Resources

Faculty Disclosure Information

Program Faculty
ANTONIO ANZUETO, MD, Professor of Medicine, University of Texas Health Science Center, San Antonio, Texas

Chief, Pulmonary Disease Section, University of Texas Health Science Center, San Antonio, Texas

Director, Pulmonary Function Laboratory, University of Texas Health Science Center, San Antonio, Texas

JOYCE ROUSE, Copywriter, TIV, Inc., St. Louis, Missouri

Program Planning Committee
ANTONIO ANZUETO, MD, Professor of Medicine, University of Texas Health Science Center, San Antonio, Texas

Chief, Pulmonary Disease Section, University of Texas Health Science Center, San Antonio, Texas

Director, Pulmonary Function Laboratory, University of Texas Health Science, San Antonio, Texas

MARGIE MILLER, Director, Continuing Medical Education, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma

JOYCE ROUSE, Copywriter, TIV, Inc., St. Louis, MO

MELISSA WIDMAN, Associate Producer, TIV, Inc., St. Louis, MO

WILLIAM OAKEY, President and CEO, TIV, Inc., St. Louis, MO

Faculty and Planning Committee Disclosure Information
It is the policy of the University of Oklahoma Health Sciences Center to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty members in these educational programs are expected to disclose to the program audience any real or apparent conflict of interest related to the content of their presentation.

Per ACCME guidelines, the following information was received from the faculty and planning committee for Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD): A CME Update:

ANTONIO ANZUETO, MD, has disclosed that he has received grants/research support from GlaxoSmithKline, he is a consultant to Bayer, Boehringer Ingelheim, GlaxoSmithKline and Pfizer and he has received honoraria from Bayer, Boehringer Ingelheim, GlaxoSmithKline and Schering-Plough.

Dr. Anzueto’s presentation will include products or services from the above-listed commercial interests and he will make clinical recommendations in this presentation based on the best available evidence.

MARGIE MILLER, University of Oklahoma College of Medicine, has no significant financial relationships to disclose.

WILLIAM OAKEY, TIV, Inc., has disclosed that he is president of TIV, Inc., a medical education company that receives commercial education grants.

JOYCE ROUSE, TIV, Inc., has disclosed that she is an employee of TIV, Inc., a medical education company that receives commercial education grants.

MELISSA WIDMAN, TIV, Inc., has disclosed that she is an employee of TIV, Inc., a medical education company that receives commercial education grants.

Conflict Resolution
The University of Oklahoma College of Medicine, Office of Continuing Medical Education has reviewed this activity’s faculty and planning committee disclosures and resolved all identified conflicts of interest, if applicable.

Copyright © 2008 TIV, Inc. All rights reserved. Produced by TIV, Inc.